BIO and BioNJ commend Governor Chris Christie for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines. Governor Christie signed Assembly Bill 2477 into law following unanimous passage in both the New Jersey Senate and Assembly earlier this year. Bill seeks to properly preserve patient access to accurate prescription information, maintain incentives for innovation, and promote a competitive market for biologic therapies.